PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China; Wuhan University Center for Pathology and Molecular Diagnostics, Wuhan, China.\', \'Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China; Wuhan University Center for Pathology and Molecular Diagnostics, Wuhan, China; Department of Pathology, University of Chicago Medicine, Chicago, IL, United States. Electronic address: syxiao@whu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0753-3322(21)00018-410.1016/j.biopha.2021.111233
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 33433350
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and inflammatory bowel disease: A pathophysiological assessment.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all